Document:

Exhibit
4.2

 

Final Form

 

Representative’s
Warrant Agreement

 

THE
REGISTERED HOLDER OF THIS WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT THIS WARRANT SHALL NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED,
OR HYPOTHECATED, OR BE THE SUBJECT OF ANY HEDGING, SHORT SALE, DERIVATIVE, PUT, OR CALL TRANSACTION THAT WOULD RESULT IN THE EFFECTIVE
ECONOMIC DISPOSITION OF THE SECURITIES FOR A PERIOD OF ONE HUNDRED EIGHTY (180 DAYS) IMMEDIATELY FOLLOWING THE EFFECTIVE DATE, AS HEREAFTER
DEFINED. THIS WARRANT IS NOT EXERCISABLE AFTER [●], 2027.

 

WARRANT

FOR
THE PURCHASE OF

[●]
SHARES OF COMMON STOCK OF

SONDORS
INC.

 

[●],
2022

 

1.
Purchase Option.

 

THIS
CERTIFIES THAT, Lake Street Capital Markets, LLC (“Holder”), as registered owner of this Warrant, is entitled, at
any time or from time to time commencing six months from the date hereof, and at or before 5:00 p.m., New York City local time, [●],
2027 (“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●]
shares of Common Stock (“Shares”), with a par value of the $0.0001 per share (the “Common Stock”),
of SONDORS Inc. (“Company”). If the Expiration Date is a day on which banking institutions are authorized by law to
close, then this Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During
the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Warrant. This Warrant is
initially exercisable at $[●] per share of Common Stock so purchased; provided, however, that upon the occurrence of any
of the events specified in Section 6 hereof, the rights granted by this Warrant, including the exercise price per Share and the
number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall
mean $[●]1 or the adjusted exercise price, depending on the context.

 

2.
Exercise.

 

2.1
Exercise Form. In order to exercise this Warrant, the exercise form (the “Exercise Form”) attached hereto must
be duly executed and completed and delivered to the Company, together with this Warrant and payment of the Exercise Price for the Shares
being purchased payable in cash or by certified check or official bank check or wire transfer. If the subscription rights represented
hereby shall not be exercised at or before 5:00 p.m., New York City local time, on the Expiration Date this Warrant shall become and
be void without further force or effect, and all rights represented hereby shall cease and expire.

 

2.2
Cashless Exercise.

 

2.2.1
Determination of Amount. If at the time of exercise hereof there is no effective registration statement registering the Shares,
or the prospectus contained therein is not available for the issuance of the Shares to the Holder, then in lieu of the payment of the
Exercise Price multiplied by the number of Shares for which this Warrant is exercisable (and in lieu of being entitled to receive Shares)
in the manner required by Section 2.1, the Holder shall have the right (but not the obligation) to convert any exercisable but
unexercised portion of this Warrant into a number of Shares (“Cashless Exercise Right”) equal to the product of (i)
X and (ii) the quotient obtained by dividing (A-B) by A:

 

	 	(A) =	 the average VWAP for the three consecutive Trading Days ending
on the date immediately preceding the date of the Exercise Notice.

 

 

1
125% of the initial public offering price.

 

    	 

    	 

    

 

	 	(B) =	 the Exercise Price, as adjusted hereunder; and
	 	(X) = 	the number of Shares that would be issuable upon exercise of this Warrant to the extent being exercised
in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

 

“Trading
Day” means a day on which the Common Stock is traded on a Trading Market.

 

“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York
Stock Exchange (or any successors to any of the foregoing).

 

“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock
so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected
in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

2.2.2
Mechanics of Cashless Exercise. The Cashless Exercise Right may be exercised by the Holder on any business day on or after the
Commencement Date and not later than the Expiration Date by delivering the Warrant with the duly executed exercise form attached hereto
with the cashless exercise section completed to the Company, exercising the Cashless Exercise Right and specifying the total number of
Shares the Holder will purchase pursuant to such Cashless Exercise Right.

 

2.3
Registration of Shares of Common Stock. The Company agrees to use its commercially reasonable efforts to maintain the effectiveness
of the Registration Statement until the expiration of the Warrants in accordance with the provisions of this Warrant Agreement; provided,
however, that the Company shall not have penalties for failure to deliver shares of Common Stock if a registration statement
is not effective or a current prospectus is not on file with the SEC at the time of exercise by the Holder. In addition, to the extent
not completed at the time of the initial issuance of the Warrants, the Company agrees to use its reasonable efforts to register such
securities under the blue sky laws of the states of residence of the exercising registered Holder to the extent an exemption under the
Act is not available for the exercise of the Warrants. In no event will the Holder be entitled to receive a net-cash settlement or Common
Stock or other consideration as of result of the Company’s non-compliance with this Section 2.3.

 

3.
Transfer.

 

3.1
General Restrictions. The registered Holder of this Warrant, by its acceptance hereof, agrees that it will not sell, transfer,
assign, pledge or hypothecate this Warrant for a period of one hundred eighty (180) days from effective date (the “Effective
Date”) of the Company’s registration statement on Form S-1 (the “Registration Statement”) filed with
the U.S. Securities and Exchange Commission (file number 333-267826) to anyone other than (i) a sales agent or selected dealer in connection
with the public offering (“Offering”), or (ii) a bona fide officer or partner of such sales agent or selected dealer.
Additionally, pursuant to FINRA Rule 5110(g), the Warrant (and the Shares underlying this Warrant) will not be the subject of any hedging,
short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period
of 180 days immediately following the Effective Date. On and after the 181 day anniversary of the Effective Date, transfers to others
may be made subject to compliance with or exemptions from applicable securities laws. In order to make any permitted assignment, the
Holder must deliver to the Company the assignment form attached hereto duly executed and completed, together with the Warrant and payment
of all transfer taxes, if any, payable in connection therewith. The Company shall within five business days transfer this Warrant on
the books of the Company and shall execute and deliver a new Warrant or Warrants of like tenor to the appropriate assignee(s) expressly
evidencing the right to purchase the aggregate number of Shares purchasable hereunder or such portion of such number as shall be contemplated
by any such assignment.

 

    	 

    	 

    

 

3.2
Restrictions Imposed by the Act. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act of 1933, as amended.

 

4.
New Warrants to be Issued.

 

4.1
Partial Exercise or Transfer. Subject to the restrictions in Section 3, this Warrant may be exercised or assigned in whole
or in part. In the event of the exercise or assignment hereof in part only, upon surrender of this Warrant for cancellation, together
with the duly executed exercise or assignment form and funds sufficient to pay any Exercise Price and/or transfer tax, the Company shall
cause to be delivered to the Holder without charge a new Warrant of like tenor to this Warrant in the name of the Holder evidencing the
right of the Holder to purchase the number of Shares purchasable hereunder as to which this Warrant has not been exercised or assigned.

 

4.2
Lost Certificate. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of
this Warrant and of reasonably satisfactory indemnification or the posting of a bond, the Company shall execute and deliver a new Warrant
of like tenor and date. Any such new Warrant executed and delivered as a result of such loss, theft, mutilation or destruction shall
constitute a substitute contractual obligation on the part of the Company.

 

5.
Adjustments.

 

5.1
Adjustments to Exercise Price and Number of Securities. The Exercise Price and the number of Shares underlying the Warrant shall
be subject to adjustment from time to time as hereinafter set forth:

 

5.1.1
Stock Dividends - Split-Ups. If after the date hereof, and subject to the provisions of Section 5.2 below, the number of
outstanding shares of Common Stock is increased by a stock dividend payable in Common Stock or by a split-up of the Common Stock or other
similar event, then the number of shares of Common Stock underlying each of the Shares purchasable hereunder shall be increased in proportion
to such increase in outstanding shares of Common Stock. In such event the Exercise Price shall be proportionately decreased.

 

5.1.2
Aggregation of Shares. If after the date hereof, and subject to the provisions of Section 5.2, the number of outstanding
shares of Common Stock is decreased by a consolidation, combination or reclassification of the Common Stock or other similar event, then
the number of shares of Common Stock underlying each of the Shares purchasable hereunder shall be decreased in proportion to such decrease
in outstanding shares. In such event the Exercise Price shall be proportionately increased.

 

5.1.3
Replacement of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding shares
of Common Stock other than a change covered by Section 5.1.1 or 5.1.2 hereof or that solely affects the par value of such
shares of Common Stock, or in the case of any merger or consolidation of the Company with or into another corporation (other than a consolidation
or merger in which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the
outstanding shares of Common Stock), or in the case of any sale or conveyance to another corporation or entity of the property of the
Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the Holder of this Warrant
shall have the right thereafter (until the expiration of the right of exercise of this Warrant) to receive upon the exercise hereof,
for the same aggregate Exercise Price payable hereunder immediately prior to such event, the kind and amount of shares of stock or other
securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution
following any such sale or transfer, by a Holder of the number of shares of Common Stock obtainable upon exercise of this Warrant immediately
prior to such event; and if any reclassification also results in a change in the number of shares of Common Stock covered by Section
5.1.1 or 5.1.2, then such adjustment shall be made pursuant to Sections 5.1.1, 5.1.2 and this Section 5.1.3.
The provisions of this Section 5.1.3 shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations,
sales or other transfers.

 

    	 

    	 

    

 

5.1.4
Changes in Form of Warrant. This form of Warrant need not be changed because of any change pursuant to this Section, and Warrants
issued after such change may state the same Exercise Price and the same number of Shares as are stated in the Warrants initially issued
pursuant to this Agreement. The acceptance by any Holder of the issuance of new Warrants reflecting a required or permissive change shall
not be deemed to waive any rights to an adjustment occurring after the Commencement Date or the computation thereof.

 

5.2
Substitute Warrant. In case of any consolidation of the Company with, or merger of the Company with, or merger of the Company
into, another corporation (other than a consolidation or merger which does not result in any reclassification or change of the outstanding
shares of Common Stock), the corporation formed by such consolidation or merger shall execute and deliver to the Holder a supplemental
Warrant providing that the holder of each Warrant then outstanding or to be outstanding shall have the right thereafter (until the stated
expiration of such Warrant) to receive, upon exercise of such Warrant, the kind and amount of shares of stock and other securities and
property receivable upon such consolidation or merger, by a holder of the number of shares of Common Stock for which such Warrant might
have been exercised immediately prior to such consolidation, merger, sale or transfer. Such supplemental Warrant shall provide for adjustments
which shall be identical to the adjustments provided in Section 5. The above provision of this Section shall similarly apply to
successive consolidations or mergers.

 

5.3
Elimination of Fractional Interests. The Company shall not be required to issue certificates representing fractions of shares
of Common Stock upon the exercise of the Warrant, nor shall it be required to issue scrip or pay cash in lieu of any fractional interests,
it being the intent of the parties that all fractional interests shall be eliminated by rounding any fraction up to the nearest whole
number of shares of Common Stock or other securities, properties or rights.

 

6.
Reservation and Listing. The Company shall at all times reserve and keep available out of its authorized shares of Common Stock,
solely for the purpose of issuance upon exercise of this Warrant, such number of shares of Common Stock or other securities, properties
or rights as shall be issuable upon the exercise thereof. The Company covenants and agrees that, upon exercise of this Warrant and payment
of the Exercise Price therefor, all shares of Common Stock shall be duly and validly issued, fully paid and non-assessable and not subject
to preemptive rights of any shareholder. As long as this Warrant shall be outstanding, the Company shall use its best efforts to cause
all Shares issuable upon exercise of this Warrant to be listed (subject to official notice of issuance) on all securities exchanges (or,
if applicable on the OTC Market or any successor trading market) on which the Shares issued to the public in connection the Registration
Statement may then be listed and/or quoted.

 

7.
Certain Notice Requirements.

 

7.1
Holder’s Right to Receive Notice. Nothing herein shall be construed as conferring upon the Holder the right to vote or consent
as a shareholder for the election of directors or any other matter, or as having any rights whatsoever as a shareholder of the Company.
If, however, at any time prior to the expiration of this Warrant and its exercise, any of the events described in Section 7.2
shall occur, then, in one or more of said events, the Company shall give written notice of such event at least fifteen (15) days prior
to the date fixed as a record date or the date of closing the transfer books for the determination of the shareholders entitled to such
dividend, distribution, conversion or exchange of securities or subscription rights, or entitled to vote on such proposed dissolution,
liquidation, winding up or sale. Such notice shall specify such record date or the date of the closing of the transfer books, as the
case may be. Notwithstanding the foregoing, the Company shall deliver to each Holder a copy of each notice given to the other shareholders
of the Company at the same time and in the same manner that such notice is given to the shareholders.

 

    	 

    	 

    

 

7.2
Events Requiring Notice. The Company shall be required to give the notice described in this Section 7 upon one or more
of the following events: (i) if the Company shall take a record of the holders of its Common Stock for the purpose of entitling them
to receive a dividend or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise than out of
retained earnings, as indicated by the accounting treatment of such dividend or distribution on the books of the Company, or (ii) the
Company shall offer to all the holders of its Common Stock any additional shares of capital stock of the Company or securities convertible
into or exchangeable for shares of capital stock of the Company, or any option, right or warrant to subscribe therefor, (iii) a dissolution,
liquidation or winding up of the Company (other than in connection with a consolidation or merger) or a sale of all or substantially
all of its property, assets and business shall be proposed, or (iv) if the Company shall deliver a notice to the Holder pursuant to Section
5.

 

7.3
Notice of Change in Exercise Price. The Company shall, promptly after an event requiring a change in the number of Shares and
Exercise Price pursuant to Section 5, send notice to the Holder of such event and change (“Price Notice”).
The Price Notice shall describe the event causing the change and the method of calculating same and shall be certified as being true
and accurate by the Company’s President or Chief Financial Officer.

 

7.4
Transmittal of Notices. All notices, requests, consents and other communications under this Warrant shall be in writing and shall
be mailed (registered or certified mail, return receipt requested), personally delivered or sent by electronic mail (email) and confirmed
and shall be deemed given when so delivered or sent via email and confirmed or if mailed, two (2) days after such mailing:

 

(i)
if to the registered Holder of this Warrant, to the address of such Holder as shown on the books of the Company, with a copy to:

 

Faegre
Drinker Biddle & Reath LLP

2200
Wells Fargo Center

90
S. Seventh Street

Minneapolis,
MN 55402

Attn:
Jonathan Zimmerman, Esq.

Email:
jon.zimmerman@faegredrinker.com

 

(ii)
if to the Company, to the following address or to such other address as the Company may designate by notice to the Holder:

 

SONDORS
Inc.

23823
Malibu Road, Suite 50 #129

Malibu,
CA 90265

Attn:
Storm Sonders

Email:
storm@sondors.com

 

With
a copy to:

 

Troutman
Pepper Hamilton Sanders LLP

5
Park Plaza, 14th Floor

Irvine,
CA 92626

Attn:
Larry Cerutti, Esq.

Email:
larry.cerutti@troutman.com

 

8.
Miscellaneous.

 

8.1
Amendments. The Company and the Holder may from time to time supplement or amend this Warrant without the approval of the Holder
in order to cure any ambiguity, to correct or supplement any provision contained herein that may be defective or inconsistent with any
other provisions herein, or to make any other provisions in regard to matters or questions arising hereunder that the Company and the
Holder may deem necessary or desirable and that the Company and the Holder deem shall not adversely affect the interest of the Holders.
All other modifications or amendments shall require the written consent of and be signed by the party against whom enforcement of the
modification or amendment is sought.

 

    	 

    	 

    

 

8.2
Headings. The headings contained herein are for the sole purpose of convenience of reference and shall not in any way limit or
affect the meaning or interpretation of any of the terms or provisions of this Warrant.

 

8.3
Entire Agreement. This Warrant (together with the other agreements and documents being delivered pursuant to or in connection
with this Warrant) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof and supersedes all
prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.

 

8.4
Binding Effect. This Warrant shall inure solely to the benefit of and shall be binding upon, the Holder and the Company and their
permitted assignees, respective successors, legal representative and assigns, and no other person shall have or be construed to have
any legal or equitable right, remedy or claim under or in respect of or by virtue of this Warrant or any provisions herein contained.

 

8.5
Noncircumvention. The Company hereby covenants and agrees that the Company will not, by amendment of its governing documents or
through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities,
or any other voluntary action, take any action designed or intended to avoid the observance or performance of any of the terms of this
Warrant, and will at all times in good faith comply with all the provisions of this Warrant.

 

8.6
Governing Law; Submission to Jurisdiction. This Warrant shall be governed by and construed and enforced in accordance with the
laws of the State of New York, without giving effect to conflict of laws. The Company hereby agrees that any action, proceeding or claim
against it arising out of, or relating in any way to this Warrant shall be brought and enforced in the courts of the State of New York
or of the United States of America for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction
shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient
forum. Any process or summons to be served upon the Company may be served by transmitting a copy thereof by registered or certified mail,
return receipt requested, postage prepaid, addressed to it at the address set forth in Section 8. Such mailing shall be deemed
personal service and shall be legal and binding upon the Company in any action, proceeding or claim. The Company and the Holder agree
that the prevailing party(ies) in any such action shall be entitled to recover from the other party(ies) all of its reasonable attorneys’
fees and expenses relating to such action or proceeding and/or incurred in connection with the preparation therefor.

 

8.7
Waiver, Etc. The failure of the Company or the Holder to at any time enforce any of the provisions of this Warrant shall not be
deemed or construed to be a waiver of any such provision, nor to in any way affect the validity of this Warrant or any provision hereof
or the right of the Company or any Holder to thereafter enforce each and every provision of this Warrant. No waiver of any breach, non-compliance
or non-fulfillment of any of the provisions of this Warrant shall be effective unless set forth in a written instrument executed by the
party or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance or non-fulfillment
shall be construed or deemed to be a waiver of any other or subsequent breach or non-compliance.

 

[Signature
Page Follows]

 

    	 

    	 

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be signed by its duly authorized officer as of the date first set forth above.

 

	 	SONDORS
    Inc.
	 	 	 
	 	By:	 
	 	Name:	Storm
    Sonders
	 	Title:	Chief
    Executive Officer

 

    	 

    	 

    

 

Form
to be used to exercise Warrant:

 

SONDERS
Inc.

23823
Malibu Road, Suite 50 #129

Malibu,
CA 90265

Attn:
Storm Sonders, Chief Executive Officer

 

Date:
__________, 202__

 

The
undersigned hereby elects irrevocably to exercise all or a portion of the within Warrant and to purchase _______Common Stock, with a
par value of $0.0001 per share, of SONDORS Inc. (the “Common Stock”) and hereby makes payment of $ ______ (at the
rate of $ ________ per Share) in payment of the Exercise Price pursuant thereto. Please issue the Common Stock as to which this Warrant
is exercised in accordance with the instructions given below.

 

or

 

The
undersigned hereby elects irrevocably to convert its right to purchase ____________ Shares purchasable under the within Warrant by surrender
of the unexercised portion of the attached Warrant (with a “Value” based of $ ____________ based on a “Market
Price” of $__________). Please issue the Shares as to which this Warrant is exercised in accordance with the instructions
given below.

 

NOTICE:
The signature to this assignment must correspond with the name as written upon the face of the Warrant in every particular, without alteration
or enlargement or any change whatever.

 

Signature(s)
Guaranteed:

 

THE
SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT
UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15).

 

    	 

    	 

    

 

INSTRUCTIONS
FOR REGISTRATION OF SECURITIES

 

Name

(Print
in Block Letters)

 

Address

 

Form
to be used to assign Warrant:

 

ASSIGNMENT

 

(To
be executed by the registered Holder to effect a transfer of the within Warrant):

 

FOR
VALUE RECEIVED, ______________________does hereby sell, assign and transfer unto ____________ the right to purchase ____________ shares
of Common Stock, with a par value of $0.0001 per share, of SONDORS Inc. (“Company”) evidenced by the within
Warrant and does hereby authorize the Company to transfer such right on the books of the Company.

 

Dated:
________, 202_

 

Signature

 

NOTICE:
The signature to this assignment must correspond with the name as written upon the face of the Warrant in every particular, without alteration
or enlargement or any change whatever.

 

Signature(s)
Guaranteed:

 

THE
SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT
UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15).Exhibit
10.2

 

NOTICE
OF GRANT OF [INCENTIVE STOCK OPTION] or [NON-QUALIFIED STOCK OPTION AWARD]

 

SONDORS
INC

2022 EQUITY INCENTIVE PLAN

 

SONDORS
Inc. (the “Company”) hereby grants this award of a [Non-qualified Stock Option] or [Incentive Stock Option] (the “Award”
or “Option”) as set forth in this Notice of Grant of [Non-qualified Stock Option Award] or [Incentive Stock Option
Award] (the “Notice”) to the Grantee designated in this Notice, pursuant to the provisions of the Company’s
2022 Equity Incentive Plan (the “Plan”) and subject to certain restrictions as outlined below in this Notice and the
additional provisions set forth in the attached Terms and Conditions of Option Award (the “Terms”). Together, this
Notice, the attached Terms and all exhibits and appendices hereto constitute the “Agreement.” The terms and conditions
of the Plan are incorporated by reference in their entirety into this Agreement. When used in this Agreement, the terms that are defined
in the Plan shall have the meanings given to them in the Plan, as modified herein (if applicable).

 

Award
Details:

 

	Grantee
    Name	 	Grant
    Date	 	Expiration
    Date 
	 	 	 	 	 
	 	 	 	 	 
	Vesting
    Commencement Date	 	No.
    of Options	 	Exercise
    Price per Share
	 	 	 	 	 

 

[This
Option is intended to qualify as an Incentive Stock Option. Nevertheless, to the extent that the Option fails to meet the requirements
of an Incentive Stock Option, this Option shall be treated as a Non-qualified Stock Option.] or [The Option is not intended to qualify
as an Incentive Stock Option.]

 

Vesting
Schedule: Subject to the terms of the Plan and this Agreement, the Option shall become vested and exercisable in accordance with
the following schedule, in the event the Grantee does not have a separation from service prior to the applicable vesting date(s) (the
“Vesting Date”):

 

	Vesting
    Date	 	Number
    of Options to Vest
	First
    anniversary of Vesting Commencement Date	 	 
	Second
    anniversary of Vesting Commencement Date	 	 
	Third
    anniversary of Vesting Commencement Date	 	 
	Fourth
    anniversary of Vesting Commencement Date	 	 

 

The
Option may be exercisable only as to a whole number of shares of Common Stock as of any given vesting date. If the number of shares of
Common Stock with respect to which the Option becomes vested and exercisable determined as of a Vesting Date is a fractional number,
the number vesting will be rounded down to the nearest whole number with any fractional portion carried forward. Exhibit A to
this Notice sets forth the terms and provisions regarding treatment of the Award upon the Grantee’s Separation from Service. The
Option shall not become vested and exercisable following the Grantee’s Separation from Service except as otherwise expressly provided
in Exhibit A to this Notice or as otherwise provided pursuant to the terms of the Plan.

 

Expiration
Date: The expiration date of the Option (the “Expiration Date”) is set forth in the Award Details above. The
Option may terminate earlier than the Expiration Date as set forth in Exhibit A to this Notice in connection with the Grantee’s
Separation from Service.

 

Award
Acceptance: The Grantee must accept the Agreement electronically pursuant to the online acceptance procedure established by the
Company by no later than three months following the Grant Date. If the Grantee does not accept the Agreement through the online acceptance
process by that date, or such other date that may be communicated, the Company will automatically accept the Agreement on the Grantee’s
behalf. If the Grantee declines the Agreement, the Award will be canceled, and the Grantee will not be entitled to any benefits from
the Award nor any compensation or benefits in lieu of the canceled award.

 

    	1

     

    

 

EXHIBIT
A

 

Treatment
Upon Separation from Service or Change in Control

 

1. Vesting
upon Separation from Service. Vesting and exercisability of any portion of the Option on a Vesting Date is conditioned on the
Grantee remaining in continuous Service through the Vesting Date. Accordingly, and except as provided by Section 3 of this
Exhibit, if the Grantee has a Separation from Service for any reason, whether voluntary or involuntary and with or without cause,
before a Vesting Date, the entire unvested portion of the Option as of the date of such Separation from Service shall be immediately
canceled and forfeited. Any outstanding, vested portion of the Option shall remain exercisable for such period as set forth in Section
2 of this Exhibit.

 

2. Exercisability
of Vested Option Following Separation from Service.

 

(a)
General Rule. Upon the Grantee’s Separation from Service other than as provided in clauses (b) and (c) below, the portion
of the Option then vested and exercisable shall remain exercisable until the earlier of (A) nine (90) days after the date of Separation
from Service or (B) the Expiration Date.

 

(b) Death
and Disability. If the Grantee has a Separation from Service as a result of the Grantee’s death or disability (as defined in
Section 22(e)(3) of the Code), the portion of the Option then vested and exercisable shall remain exercisable until the earlier of (A)
one year from the date of such death or disability or (B) the Expiration Date. Following a Grantee’s death, the Option shall be
exercisable by the person entitled to do so under the will of the Grantee, or, if the Grantee shall fail to make testamentary disposition
of the Option or shall die intestate, by the legal representative of the Grantee.

 

(c) Cause.
If the Grantee has a Separation from Service by action of the Company for Cause, the entire Option, including any vested and unvested
portion, shall expire immediately upon such Separation from Service. For this purpose, “Cause” shall have the meaning set
forth in any employment agreement between the Company and the Grantee, and if there is no such agreement, “Cause” means dismissal
as a result of (i) the commission of any act by the Grantee constituting financial dishonesty against the Company or its Subsidiaries
(which act would be chargeable as a crime under applicable law); (ii) the Grantee’s engaging in any other act of dishonesty, fraud,
intentional misrepresentation, moral turpitude, illegality or harassment which, as determined in good faith by the Committee, would:
(A) materially adversely affect the business or the reputation of the Company or any of its Subsidiaries with their respective current
or prospective customers, suppliers, lenders and/or other third parties with whom such entity does or might do business; or (B) expose
the Company or any of its Subsidiaries to a risk of civil or criminal legal damages, liabilities or penalties; (iii) the repeated failure
by the Grantee to follow the lawful directives of the chief executive officer of the Company or any of its Subsidiaries or the Committee,
or (iv) any material misconduct, violation of the Company’s or Subsidiaries’ policies, or willful and deliberate non-performance
of duty by the Grantee in connection with the business affairs of the Company or its Subsidiaries.

 

3. Change
in Control. Upon a Change in Control, the Option shall be treated in accordance with the provisions of Section 15.3.1 of the Plan.

 

    	 	 	 

     

    

 

2022
EQUITY INCENTIVE PLAN

 

TERMS
AND CONDITIONS OF STOCK OPTION AWARD

 

The
award of a non-statutory stock option (the “Award” or “Option”) granted by SONDORS Inc. (the “Company”)
to the Grantee specified in the Notice of Grant of Incentive Stock Option or Non-statutory Stock Option Award, as applicable (the “Notice”)
to which these Terms and Conditions of Stock Option Award (the “Terms”) are attached, is subject to the terms and
conditions of the Plan, the Notice, and these Terms. The terms and conditions of the Plan are incorporated by reference in their entirety
into these Terms. The Notice and these Terms (including any exhibits or appendices) together constitute the “Agreement.”
A Prospectus describing the Plan has been delivered to the Grantee. The Plan itself is available upon request. When used in this Agreement,
the terms which are defined in the Plan shall have the meanings given to them in the Plan, as modified herein (if applicable).

 

	1.	Grant of Option.

 

(a) As
of the Grant Date set forth in the Notice, the Company grants to the Grantee an Option to purchase a number of shares of Common Stock
set forth in the Notice and Grant Summary, subject to the terms and conditions of the Plan and this Agreement.

 

(b) The
Option shall become vested and exercisable in accordance with the schedule set forth in the Notice.

 

(c) The
Option shall terminate upon the earlier to occur of: (i) the Expiration Date set forth in the Notice; or (ii) the expiration of the applicable
period following the Grantee’s Separation from Service as set forth in the Notice. The Company shall have no obligation to provide
the Grantee with notice of termination or expiration of the Option.

 

	2.	Exercise of Option.

 

(a) Notice
of Exercise. Subject to the terms of the Plan and this Agreement, the Option, to the extent vested and exercisable, shall be exercised
pursuant to procedures established by the Committee, which may include electronic or voice procedures as may be specified by the Committee
and which may include a requirement to acknowledge this Agreement prior to exercise.

 

(b) Minimum
Exercise Requirements. Unless otherwise determined by the Company, the Option must be exercised for at least one hundred (100) shares
of Common Stock, or, if the number of shares subject to the unexercised portion of the Option is less than 100, all of the remaining
shares subject to the Option.

 

(c) Payment
of Exercise Price. If the Grantee elects to exercise the Option by submitting an exercise notice under Section 2(a) of this Agreement,
the aggregate Exercise Price shall be paid by cash or certified check; provided, however, that the Committee may authorize payment to
be made in any of the following additional forms, or a combination of them:

 

i. by
a broker-assisted cashless exercise procedure;

 

ii.
by tendering shares of Stock acceptable to the Committee valued at their Fair Market Value as of the date of exercise;

 

    	2

     

    

 

iii. a
“net exercise” under which the Company reduces the number of shares of Common Stock issued upon exercise by the largest whole
number of shares with a Fair Market Value that does not exceed the aggregate Exercise Price (with cash for any difference); or

 

iv.
any other consideration that the Board deems appropriate and in compliance with applicable law.

 

(d) Issuance of Shares Upon Exercise.
Subject to this Agreement, the Company shall issue, in book-entry (electronic) form, the number of shares of Common Stock to which the
Grantee (or other permitted person following the Grantee’s death) is entitled as soon as practicable after the date of exercise.
Unless the person exercising the Option otherwise directs the Company in writing, the book-entry will be made in the name of the person
exercising the Option and delivered to such person. (If the person exercising the Option directs the Company to register the Common Stock
in the name of another, the person exercising the Option should consult his or her tax advisor on the gift tax implications of such registration.)
For income tax purposes, the shares of Common Stock shall be considered transferred to the Grantee on the date on which the Option is
exercised with respect to such shares. Until such time as the Option has been duly exercised and shares of Common Stock have been delivered,
the Grantee shall not be entitled to exercise any voting rights with respect to such shares and shall not be entitled to receive dividends
or other distributions with respect thereto.

 

	3.	Responsibility for Taxes.

 

(a) Regardless
of any action the Company takes with respect to any or all income tax, payroll tax or other tax-related withholding (“Tax-Related
Items”), the Grantee acknowledges that the ultimate liability for all Tax-Related Items owed by the Grantee is and remains
the Grantee’s responsibility and that the Company or a Subsidiary that the Grantee is employed by or provides services to (the
“Employer”) (i) makes no representations or undertakings regarding the treatment of any Tax-Related Items in connection
with any aspect of the Award, including the grant, vesting or exercise of the Option or the subsequent sale of any shares of Common Stock
acquired upon exercise; and (ii) does not commit to structure the terms of the grant or any aspect of the Award to reduce or eliminate
the Grantee’s liability for Tax-Related Items.

 

(b) Prior
to the exercise of the Option, the Grantee shall pay or make adequate arrangements satisfactory to the Company to satisfy all withholding
obligations of the Company or Employer. In this regard, the Grantee authorizes the Company and/or Employer to withhold all applicable
Tax-Related Items legally payable by the Grantee from the Grantee’s wages or other cash compensation paid to the Grantee by the
Company or Employer or from proceeds of the sale of any shares of Common Stock. Alternatively, or in addition, to the extent permissible
under applicable law, the Company or Employer may (i) sell or arrange for the sale of any shares of Common Stock that the Grantee acquires
to meet the withholding obligation for Tax-Related Items, and/or (ii) withhold shares of Common Stock otherwise issuable upon exercise
of the Option in an amount necessary to satisfy the withholding obligation for Tax-Related Items. Finally, the Grantee shall pay to the
Company and/or Employer any amount of Tax-Related Items that the Company may be required to withhold as a result of the Grantee’s
participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue and deliver shares
of Common Stock upon exercise of the Option if the Grantee fails to comply with the Grantee’s obligations in connection with the
Tax-Related Items as described in this Section 3.

 

    	3

     

    

 

(c) If
the Notice indicates that the Award is intended to be an Incentive Stock Option and if the Grantee makes any disposition of Shares delivered
pursuant to the exercise of the Option under the circumstances described in Section 421(b) of the Code (relating to certain disqualifying
dispositions) or any successor provision of the Code, the Grantee shall notify the Company of such disposition within ten days of such
disposition.

 

	4.	Grantee Representations. The Grantee hereby represents
to the Company that the Grantee has read and fully understands the provisions of this Agreement, the Prospectus and the Plan, and the
Grantee’s decision to participate in the Plan is completely voluntary. Further, the Grantee acknowledges that the Grantee is relying
solely on his or her own advisors with respect to the tax consequences of this Award.

 

	5.	Regulatory Restrictions on the Shares Issued Upon Exercise.
Notwithstanding the other provisions of this Agreement, the Committee shall have the sole discretion to impose such conditions, restrictions
and limitations on the issuance of shares of Common Stock with respect to this Award unless and until the Committee determines that such
issuance complies with (i) any applicable registration requirements under the Securities Act or the Committee has determined that an
exemption therefrom is available, (ii) any applicable listing requirement of any stock exchange on which the Common Stock is listed,
(iii) any applicable Company policy or administrative rules, and (iv) any other applicable provision of state, federal or foreign law,
including foreign securities laws where applicable.

 

	6.	Miscellaneous.

 

(a) Notices.
Any notice which either party hereto may be required or permitted to give to the other shall be in writing and may be delivered personally,
by intraoffice mail, by fax, by electronic mail or other electronic means, or via a postal service, postage prepaid, to such electronic
mail or postal address and directed to such person as the Company may notify the Grantee from time to time; and to the Grantee at the
Grantee’s electronic mail or postal address as shown on the records of the Company from time to time, or at such other electronic
mail or postal address as the Grantee, by notice to the Company, may designate in writing from time to time.

 

(b) Waiver.
The waiver by any party hereto of a breach of any provision of this Agreement shall not operate or be construed as a waiver of any other
or subsequent breach.

 

(c) Entire
Agreement. This Agreement and the Plan constitute the entire agreement between the parties with respect to the subject matter hereof.
Any prior agreements, commitments or negotiations concerning the Award are superseded.

 

(d) Binding
Effect; Successors. This Agreement shall inure to the benefit of and be binding upon the parties hereto and to the extent not prohibited
herein, their respective heirs, successors, assigns and representatives. Nothing in this Agreement, express or implied, is intended to
confer on any person other than the parties hereto and as provided above, their respective heirs, successors, assigns and representatives
any rights, remedies, obligations or liabilities.

 

    	4

     

    

 

(e) Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware without giving effect
to the principles of conflicts of law, and applicable Federal law.

 

(f) Dispute
Resolution; Venue. Any dispute or disagreement which shall arise under or in any way relate to the interpretation or construction
of the Plan or this Agreement shall be resolved by the Committee and the decision of the Committee shall be final, binding and conclusive
for all purposes. The Grantee and the Company and their respective heirs, representatives, successors and assigns irrevocably submit
to the exclusive and sole jurisdiction and venue of the state courts of Los Angeles, California and the federal courts of the Central
District of California with respect to any and all disputes arising out of or relating to the Plan, this Agreement, and/or the Options,
including but not limited to any disputes arising out of or relating to the interpretation and enforceability of this Option Award or
the terms and conditions of the Plan, and agree that (a) sole and exclusive appropriate venue for any such action shall be such California
courts, and no other, (b) all claims with respect to any such action shall be heard and determined exclusively in such California courts,
and no other, (c) such Pennsylvania courts shall have sole and exclusive jurisdiction over the Grantee and the Company and over the subject
matter of any dispute relating hereto and (d) the Grantee and the Company waive any and all objections and defenses to bringing any such
action before such California courts, including but not limited to those relating to lack of personal jurisdiction, improper venue or
forum non conveniens.

 

(g) Headings.
The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the meaning
or interpretation of any of the terms or provisions of this Agreement.

 

(h) Conflicts;
Amendment. The provisions of the Plan are incorporated in this Agreement in their entirety. In the event of any conflict between
the provisions of this Agreement and the Plan, the provisions of the Plan shall control. The Committee has plenary authority to interpret
the Plan and any Award thereunder, and prescribe such rules, regulations and procedures in connection with the operations of the Plan
as it shall deem to be necessary and advisable for the administration of the Plan consistent with its purposes. This Agreement may be
amended at any time by the Committee, provided that no amendment may, without the consent of the Grantee, materially impair the Grantee’s
rights with respect to the Award. All other amendments to the Agreement shall be in writing (including electronic amendments) and executed
on behalf of the Company and by the Grantee. The Committee shall have full authority and discretion, subject only to the terms of the
Plan, to decide all matters relating to the administration or interpretation of the Plan, the Award, and the Agreement, and all such
action by the Committee shall be final, conclusive, and binding upon the Company and the Grantee.

 

(i) No
Right to Continued Service. Nothing in this Agreement shall confer upon the Grantee any right to continue in Service or affect the
right of the Company or Employer to terminate the Grantee’s Service at any time.

 

(j) Further
Assurances. The Grantee agrees, upon demand of the Company or the Committee, to do all acts and execute, deliver and perform all
additional documents, instruments and agreements which may be reasonably required by the Company or the Committee, as the case may be,
to implement the provisions and purposes of this Agreement and the Plan.

 

(k) Severability.
The provisions of this Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable,
in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.

 

(l) Restrictive
Covenants. To the extent allowed by and consistent with applicable law and any applicable limitations period, if it is determined
at any time that the Grantee has materially breached any employment-related covenants under any written agreement with the Company, the
Company will be entitled to (i) cause any unvested portion of the Award to be immediately canceled without any payment of consideration
by the Company and (ii) recover from the Grantee in its sole discretion some or all of the shares of Stock (or proceeds received by the
Grantee from such shares of Stock) issued to the Grantee upon exercise pursuant to this Agreement. The Grantee recognizes that if the
Grantee breaches any such covenants, the losses to the Company may amount to the full value of any shares of Stock issued to the Grantee
upon exercise pursuant to this Agreement.

 

    	5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}]]